Introduction Immune-checkpoint inhibitors (ICIs) have emerged as a core pillar of cancer
therapy as single agents or in combination regimens both in adults and children …

Introduction: Network pharmacology has emerged as a forefront and hotspot in anti-cancer.
Traditional anti-cancer drugs are limited by the paradigm of “one cancer, one target, one …

Esophageal carcinoma is the sixth leading cause of cancer death globally and the majority
of global cases are esophageal squamous cell carcinoma (ESCC). Difficulty in diagnosis …

Background: Breast cancer (BC) is a heterogeneous tumor with a variety of etiology and
clinical features. Antibody-dependent cell phagocytosis (ADCP) is the last step of immune …

Background Fibroblasts are necessary to the progression of cancer. However, the role of
fibroblasts in peritoneal metastasis (PM) of gastric cancer (GC) remains elusive. In this study …

Background Esophageal squamous cell carcinoma (ESCC), characterized by its high
invasiveness and malignant potential, has long been a formidable challenge in terms of …

Because cancer is a leading cause of death and is thought to be caused by genetic errors or
genomic instability in many circumstances, there have been studies exploring cancer's …

Simple Summary Esophageal squamous cell cancer (ESCC) is an aggressive disease
associated with a poor prognosis. The oxidative stress-related long non-coding RNAs …

Ovarian cancer (OC) is the leading cause of gynecological cancer death. Cancer-associated
fibroblasts (CAF) is involved in wound healing and inflammatory processes, tumor …

Purpose Immunogenic cell death (ICD) is a type of regulated cell death that modifies the
immune response by releasing DAMPs or danger signals. Herein, we aimed to develop an …